Systematic review and meta analysis A systematic review and meta-analysis of the incidence rate of Takayasu arteritis

Objectives: Takayasu arteritis (TAK), is a rare autoimmune rheumatic disease causing large vessel vasculitis. Onset is typically between the ages of 20-30. It is associated with substantial morbidity and mortality, notably due to its effects on the cardiovascular system. It has a poorly understood global epidemiology. Our objective was to systematically review the available evidence in order to calculate the incidence rate of TAK. Methods: Three databases (Medline, PubMed and Embase) were searched in November 2019 and the results were screened by two reviewers. A random effects meta-analysis was then conducted in R to calculate the overall incidence rate. Heterogeneity was assessed using I2. The quality of the studies was assessed using an adapted Newcastle-Ottawa scale. Further sub-group analyses were performed by quality, sex, research setting and geographical location. Publication bias was assessed using a Beggs funnel plot. Results: The incidence rate for TAK per million person-years with 95% confidence intervals was 1.11 per million person years (95% CI 0.75 - 1.65). The heterogeneity in the data was extremely high in all analyses, which suggests that there was considerable variation in incidence rates across the different populations studied. TAK was found to be more common in women (incidence rate 2.01 per million person-years, 95% CI 1.39 - 2.90). Conclusions: TAK is an extremely rare disease. It affects women more commonly than men. There is considerable variation in the incidence rate between populations. We suggest that future research should focus on discrete populations in order to better identify genetic and environmental risk factors.

[1]  R. Hubbard,et al.  Risk of death among people with rare autoimmune diseases compared to the general population in England during the 2020 COVID-19 pandemic , 2020, Rheumatology.

[2]  M. Bythell,et al.  O36 Validation of methods to enable national registration for rare autoimmune rheumatic diseases , 2020 .

[3]  P. Goryński,et al.  Takayasu's arteritis: a rare disease in Poland. , 2018, Annals of agricultural and environmental medicine : AAEM.

[4]  Fatos Onen,et al.  Epidemiology of Takayasu arteritis. , 2017, Presse medicale.

[5]  H. Ahn,et al.  Incidence, prevalence, mortality and causes of death in Takayasu Arteritis in Korea - A nationwide, population-based study. , 2017, International journal of cardiology.

[6]  J. Nossent,et al.  Frequency, presentation, and outcome of Takayasu arteritis in Western Australia , 2017, Modern rheumatology.

[7]  Ø. Molberg,et al.  Prevalence, Incidence, and Disease Characteristics of Takayasu Arteritis by Ethnic Background: Data From a Large, Population‐Based Cohort Resident in Southern Norway , 2017, Arthritis care & research.

[8]  G. Nesher,et al.  The Incidence of Primary Systemic Vasculitis in Jerusalem: A 20-year Hospital-based Retrospective Study , 2016, The Journal of Rheumatology.

[9]  D. Solmaz,et al.  Epidemiology of Takayasu's arteritis in Turkey. , 2016, Clinical and experimental rheumatology.

[10]  H. Direskeneli,et al.  The epidemiology of Takayasu arteritis: a hospital-based study from northwestern part of Turkey , 2016, Rheumatology International.

[11]  T. Mandl,et al.  Takayasu Arteritis in Southern Sweden , 2015, The Journal of Rheumatology.

[12]  J. Hernández-Rodríguez,et al.  Epidemiological study of primary systemic vasculitides among adults in southern Spain and review of the main epidemiological studies. , 2015, Clinical and experimental rheumatology.

[13]  P. Shekelle,et al.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement , 2015, Systematic Reviews.

[14]  George F Borm,et al.  The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method , 2014, BMC Medical Research Methodology.

[15]  P. Tugwell,et al.  The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .

[16]  Peter W Lane,et al.  Meta-analysis of incidence of rare events , 2013, Statistical methods in medical research.

[17]  L. Dreyer,et al.  A population-based study of Takayasu´s arteritis in eastern Denmark. , 2011, Clinical and experimental rheumatology.

[18]  D. Scott,et al.  The epidemiology of Takayasu arteritis in the UK. , 2009, Rheumatology.

[19]  K. Maksimowicz-McKinnon,et al.  Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients. , 2007, Arthritis and rheumatism.

[20]  K. Koide Takayasu arteritis in Japan , 2005, Heart and Vessels.

[21]  Guy Hoffman,et al.  Takayasu Arteritis , 1994, Annals of Internal Medicine.